Dr. John Michael Varlotto

Penn State University, USA

Email: jvarlotto@hmc.psu.edu

Qualifications

1989  M.Sc., University of Pittsburgh School of Medical

1985  B.Sc., Washington & Jefferson College

Publications (selected)

1. Varlotto JM, Medford-Davis LN, Recht A, Flcikinger JC, Schaefer E, Shelkey J, Lazar M, Campbell D, Nikolov M, DeCamp M. Confirmation of the role of diabetes in the local recurrence of surgically-resected non-small cell carcinoma of the lung. Lung Cancer 2012; 75(3):381-90.
2. Statin Use is Associated with Decreased Local Recurrence and Improved Overall Survival in Resectable Non-Small Cell Lung Cancer (NSCLC). Ramakrishna S, Adrei A-C, Varlotto J, Colosimo A, Medford-Davis LN, Meyerson S, de Hoyos A, DeCamp MM. Oral presentation at Chest, Atalnta, GA, 2012.
3. Matched-Pair Comparison of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated with Resection or Stereotactic Radiosurgery. Shelkey J, Fakiris A, Varlotto J, Flickinger J, Medford-Davis L, Liss A, Belani C, DeLuca J, Recht A, Maheshwari N, DeCamp M. Poster Presentation at ASCO, Chicago, IL June 2012.
4. Varlotto JM, Medford-Davis LN, Recht A, Flickinger JC, Schaefer E, Zander D, DeCamp MM. Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? J Thorac Oncol 2011; 6(6): 1050-8.
5. Using during RT PET to Individualize Adaptive RT for Patients with Stage III NSCLC: A RTOG Planning Study. Kong FP, Machtay M, Loo BW, Gore E, Wagner H, Varlotto J, Faria S, Dilling TJ, Sun A. Poster Session at ASTRO 2011, Miami FL October 2011.
6. Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, DeCamp MM. Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically-resected stage I non-small cell lung cancer. Cancer 2010; 116(10):2390-400.
7. Changes in Prognostic Factors for Glioblastoma between 1998-2006 in the SEER Database. Flickinger JC, Lunsford LD, Kondziolka D, Lieberman FS, Wagner H, McInerney J, Shehan J, Varlotto JM. Poster Viewing Presentation at ASTRO 2010, San Diego, CA. November 2010.
8. Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, DeCamp MM. Factors Associated with Local and Distant Recurrence and Survival in Patients with Resected Non-Small Cell Lung Cancer. Cancer 2009 115(5): 1059-69.
9. Varlotto JM, Recht A, Nikolov M, Flickinger JC, DeCamp MM. Extent of Lymphadenectomy and Outcome for Patients with Stage I Non-Small Cell Lung Cancer. Cancer 2009; 115(4):851-8.
10. Varlotto JM, Flickinger JC, Recht A, Nikolov MC, DeCamp MM. Survival and DSS of Surgically Resected, Node-Positive Bronchioloalveolar Carcinoma vs. Non-Small Cell Lung Cancer. Am J Hem/Onc 7(7):278-288.
11. Preoperative identification of Stage I non-small cell lung cancer patients at high risk for local recurrence following limited resection. Medford-Davis LN, Varlotto JM, Recht A, Flickinger JC, Dyer AM, DeCamp M. Oral Presentation at ASTRO 2009, Chicago, IL. November 2009.
12. Varlotto JM, Flickinger JC, Recht A, Nikolov M, DeCamp MM. A Comparison of the Survival and Disease-Specific Survival of Surgically-Resected, Node- Positive Bronchioloalveolar Carcinoma to that of Non-Small Cell Lung Cancer: Implications for Adjuvant Therapy. Cancer, 2008 112(7):1547-54.
13. Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence. Varlotto JM, Flickinger JC, Medford-Davis LN, DeCamp MM, Recht A. Poster Presentation at ASCO 2008, Chicago, IL. June 2008.
14. Extent of lymphadenectomy (LA) and outcome for patients with stage I non-small cell lung cancer (NSCLC). DeCamp MM, Recht A, Nikolov M, Flickinger JC, Varlotto JM. Poster Presentation at ASCO 2007 Chicago, IL. June 2007.
15. Gerszten K, Colonello K, Heron DE, Lalonde RJ, Fitian ID, Comerci JT, Selvaraj RN, Varlotto JM. Feasibility of Concurrent Cisplatin and Extended Field Radiation Therapy (EFRT) Using Intensity Modulated Radiotherapy (IMRT) for Carcinoma of the Cervix. Gyn Oncol, 2006 102(2):182-8.
16. Varlotto JM, Gerszten K, Heron DE, Comerci J, Gautam S, Selvaraj R, LaLonde R, Chura JC. The Potential Nephrotoxic Effects of Intensity Modulated Radiotherapy Delivered to the Para-aortic Area of Women with Gynecologic Malignancies: Preliminary Results. Am J Clin Oncol, 2006 29(3): 281-289.
17. Varlotto JM, Stevenson MA. Anemia, Hypoxemia, and the Cancer Patient. Int J Radiat Oncol Biol Phys, 2005 63(1): 25-36.
18. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD. The Impact of Whole Brain Radiotherapy on the Long-Term Control and Morbidity of Patients surviving more than One Year after Gamma Knife Radiosurgery for Brain Metastases. Int J Radiat Oncol Biol Phys 2005 62(4):1125-1132.

Profile Details

NULL